Ovarian Cancer Screening and AI

ConditionOvarian Cancer Screening Recommendations by Gynecologists

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age24+

SponsorCharite University, Berlin, Germany

About this trial

Gynecologists frequently overestimate the benefits and safety of ovarian cancer screening. AI-supported discussions may help correct these misperceptions. This study tests whether an AI-guided conversation about the evidence on ovarian cancer screening can improve gynecologists' knowledge and reduce non-evidence-based screening recommendations, compared with a control AI discussion on ovarian cancer prevalence.

Eligibility criteria

Qualifiers

gynecologists in outpatient care who provide ovarian cancer screening to asymptomatic, average-risk women (not guideline consistent)

Disqualifiers

gynecologists in inpatient care

gynecologist in outpatient care who do NOT provide ovarian cancer screening to asymptomatic, average-risk women (guideline consistent)

Trial design

Treatments tested in this trial

ChatGPT - Control
ChatGPT - Evidence-Based Screening Discussion

Treatment groups

350 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Charite University, Berlin, Germany

Lead sponsor

Max Planck Institute for Human Development

Collaborator

German Research Foundation

Collaborator

Source ClinicalTrials.gov